Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom
Allergy · 2024
DOI: 10.1111/all.16128 ↗Kurz gefasst
Leserbrief in der Zeitschrift Allergy, 2024. Verfasst von Bogusia Kasternow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Royal Surrey NHS Foundation Trust, Guildford, UK. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Hymenoptera, Aluminum Hydroxide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Royal Surrey NHS Foundation Trust, Guildford, UK.
- Frimley Health NHS Foundation Trust, Frimley, UK.
ORCID-Profile: Da-In S Kim, Patrick F K Yong
Zitieren
APA
Kasternow, B., Kim, D. S., & Yong, P. F. K. (2024). Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom. Allergy. https://doi.org/10.1111/all.16128
Vancouver
Kasternow B, Kim DS, Yong PFK. Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom. Allergy. 2024. doi:10.1111/all.16128
BibTeX
@article{Kasternow2024,
author = {Kasternow, Bogusia and Kim, Da-In S and Yong, Patrick F K},
title = {Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.16128}
}
EUVIMED